Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Now Open Latest News 650x100px
Document › Details

Bruker Corporation. (5/4/18). "Press Release: Bruker Corporation to Present at the 43rd Annual Deutsche Bank Health Care Conference". Billerica, MA.

Region Region Boston, MA
  Country United States (USA)
Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Organisation 2 Deutsche Bank (Group)
Products Product Deutsche Bank Annual Health Care Conference 2018 Boston
  Product 2 analytical instrument
Index term Index term Bruker–Deutsche Bank: investor conference, 201805 supply service Bruker presents at Deutsche Bank Annual Health Care Conference
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations)
     


Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 43rd Annual Deutsche Bank Health Care Conference in Boston. Frank Laukien, President and CEO, will present on behalf of the company on Tuesday, May 8th, 2018 at 10:00 AM Eastern Time.

A live audio webcast of the presentation will be available on the Investors section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.


About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.


Contact :
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

   
Record changed: 2023-06-05

Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Latest News 650x200px

More documents for Bruker (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x300px




» top